Sigmapharm Arzneimittel

What Sigmapharm Arzneimittel does

Sigmapharm Arzneimittel GmbH is a privately held Austrian pharmaceutical company headquartered at Leystraße 129, Vienna, with 51–100 employees and a market presence in Austria of more than 60 years. Together with its manufacturing partner MoNo chem-pharm Produkte GmbH, the company develops, produces, and sells medicinal products and medical devices specialising in sterile and non-sterile liquid formulations for Ear, Nose and Throat (ENT) applications. Its product portfolio comprises two medicinal products — COLDAN Eye Drops (naphazoline-based, for non-infectious conjunctival irritation) and VERTIROSAN Drops (dimenhydrinate-based, for vertigo, nausea, and travel sickness) — and four medical devices: NORMISON Ear Spray, CERUSTOP Ear Oil, COLDAMARIS Nasal and Throat Spray (isotonic sea-salt with tyloxapol), and ULTRASTOP pro med. Solution (sterile anti-fog agent for medical optics). Manufacturing is anchored at GMP-certified facilities in Vienna (Leystraße and Passettistraße) with a GDP-certified warehouse in Müllendorf, supporting wholesale distribution of medicinal products and active substances across all three sites.

Sigmapharm's primary go-to-market is sales-led and pharmacy-exclusive: own-brand products are distributed through public pharmacies in Austria, with international reach into more than 50 countries via export partners and licensing arrangements. The company also operates a B2B services line for other pharmaceutical manufacturers, providing regulatory affairs support, GMP/GDP-compliant storage, and distribution and sales-organisation services. Dedicated contact channels ([email protected] for regulatory, [email protected] for distribution/export and storage) and a scientific field-service team that advises physicians and pharmacists underscore a relationship-driven commercial motion. The company is led by Managing Directors DI Dr. Bernhard Wittmann and Mag. Gabriele Horwath-Berrer, both designated as CEO, and operates with no disclosed external investor or venture-capital backing. No public revenue, ARR, or headcount time-series is disclosed, and no funding rounds, M&A activity, or product-launch cadence with dated milestones are recorded in the available sources.

Name

Sigmapharm Arzneimittel

Legal name

Sigmapharm Arzneimittel GmbH

Website

https://sigmapharm.at

Company type

Private

Founded year

1949

Operating status

Operating

Headcount range

11–50 employees

Short description

Sigmapharm Arzneimittel GmbH is a privately held Austrian pharmaceutical company that develops, produces, and sells sterile and non-sterile liquid medicinal products and medical devices for Ear, Nose and Throat applications, distributing through Austrian pharmacies and export partners in more than 50 countries.

Ownership category

akta.pro rank

Product category

ENT Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412), Drugs and Druggists' Sundries Merchant Wholesalers (42421)

SIC

Pharmaceutical Preparations (2834), Ophthalmic Goods (3851), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro industry

PRIMARYHLAIAAAH

Respiratory & Allergy Pharmaceuticals

Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals

SECONDARYHLAIADAC

Allergy, Sinus & Respiratory (Non-Asthma)

Healthcare & Life Sciences/Pharmaceuticals/Over-the-Counter (OTC) Medicines

SECONDARYHLAIABAF

Ophthalmic & Otic Generics

Healthcare & Life Sciences/Pharmaceuticals/Generic Pharmaceuticals

SECONDARYHLAHAIAK

Nasal Drug Delivery Devices (Sprays/Powder Devices)

Healthcare & Life Sciences/Medical Devices & Diagnostics/Drug Delivery Devices (Injectors, Pumps, Inhalers)

Keywords

• ENT pharmaceuticals
• Sterile liquid formulations
• Ear nose throat products
• Medical devices
• Pharmaceutical distribution

Headquarters

HQ city

Vienna

HQ country

Austria

HQ region

Europe

Offices4 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Supply Chain, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Pharmaceutical products sales: Sale of proprietary medicinal products and medical devices for ENT applications through pharmacy distribution channels in Austria and export markets

Go-to-market motion1 record

Distribution channels3 records

Marketing channels3 records

Core offering

Sigmapharm Arzneimittel GmbH develops, produces, and distributes a focused portfolio of sterile and non-sterile liquid pharmaceutical products and medical devices for ear, nose, and throat (ENT) applications, sold exclusively through public pharmacies in Austria and via export and licensing partners in 50+ countries. The portfolio spans medicinal products (COLDAN Eye Drops, VERTIROSAN Drops) and medical devices (NORMISON Ear Spray, CERUSTOP Ear Oil, COLDAMARIS Nasal and Throat Spray, ULTRASTOP pro med. Solution), with manufacturing handled by partner MoNo chem-pharm Produkte GmbH under GMP and GDP certification.

Product overview

Sigmapharm Arzneimittel GmbH is an internationally operating Austrian pharmaceutical company specializing in sterile and non-sterile liquid products for Ear, Nose, and Throat (ENT) applications. The product portfolio comprises two categories: medicinal products (COLDAN Eye Drops, VERTIROSAN Drops) containing active pharmaceutical ingredients for specific therapeutic effects, and medical devices (NORMISON® Ear Spray, CERUSTOP® Ear Oil, COLDAMARIS Nasal and Throat Spray, ULTRASTOP pro med. Solution) designed for moisturizing, cleansing, and protective functions. The company also offers complementary services including regulatory services, distribution/export, and storage and sales organisation.

Differentiator

Problem solved

Functional benefit

Brands

• COLDAN: Brand of eye drops containing naphazoline for treatment of non-infectious conjunctival irritation
• NORMISON®
• CERUSTOP®
• COLDAMARIS
• ULTRASTOP pro med.
• VERTIROSAN

Products and services

• COLDAN Eye Drops Medicinal product (eye drops) containing naphazoline that constricts conjunctival vessels, reducing swelling and inhibiting eye secretions. Indicated for non-infectious irritation of the conjunctiva caused by light, smoke, chemicals, dust, or drafts. Sold through public pharmacies.
• NORMISON Ear Spray Medical device ear spray that dries the skin surface of the auditory canal and helps re-establish its natural acid coating. Contains dexpanthenol for skin protection. Used to prevent inflammation of the external auditory canal after water exposure from swimming, diving, or bathing. Sold through public pharmacies.
• CERUSTOP Ear Oil Medical device ear oil based on almond oil that penetrates earwax to make it more soluble and easily removable. Prevents inflammation of the external auditory canal and is suitable for ear rinsing by practitioners and ENT specialists. Sold through public pharmacies.
• COLDAMARIS Nasal and Throat Spray Sterile isotonic medical device spray containing standardised sea salt and tyloxapol. Moistens nasal and pharyngeal mucosa, relieves dryness, supports nasal cleansing, and dissolves mucus during colds and hay fever. Sold through public pharmacies.
• ULTRASTOP pro med. Solution Sterile anti-fogging solution for medical optics. Surface-active substances form a transparent film that prevents droplet formation and fogging. Used for sterile endoscopies and medical examination mirrors and optics. Sold through specialty medical supply channels.
• VERTIROSAN Drops Medicinal product (oral drops) containing dimenhydrinate, an antihistaminic agent with antiemetic and antivertiginous effects. Indicated for prophylaxis and treatment of vertigo, nausea, and vomiting of different origin as well as travel sickness. Pack size 20 ml glass bottle with dropper. Sold through public pharmacies.
• Regulatory Services Service for other pharmaceutical companies covering regulatory affairs, marketing authorisation support, and product positioning in the Austrian and international markets, leveraging Sigmapharm's expertise with authorisations across 50+ countries.
• Distribution and Export Distribution and export service for pharmaceutical manufacturers, handling international logistics and sales channel development for medicinal products and medical devices.
• Storage and Sales Organisation GMP/GDP-compliant storage and sales organisation services provided to other pharmaceutical manufacturers for products positioned in the Austrian market.

Quantifiable outcome

• Products available in 50+ countries
• +1 more outcomes

Named customers3 records

Segments2 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

One partnership is on record.

• MoNo chem-pharm Produkte GmbHcoreStrategic or Co-development PartnerMoNo is the manufacturing company for Sigmapharm, producing their pharmaceutical products and medical devices. Together they form an integrated pharmaceutical company offering development, production, and sales of medicinal products and medical devices. MoNo handles the manufacturing operations while Sigmapharm manages sales and distribution.

Scale indicators3 records

Recent moves5 records

Expansion highlights5 records

Broad incumbents

• Dermapharm Holding SE: German specialty pharma focused on branded generics and OTC healthcare products with strong DACH presence. Comparable in size and business model to a mid-sized Austrian specialty pharma with OTC distribution.
• STADA Arzneimittel AG: Large European specialty and generic pharmaceutical group with extensive ENT, respiratory, and consumer health portfolios distributed across 50+ countries. Most relevant broad incumbent comparable for a niche European specialty pharma with international reach.
• Angelini Pharma: Privately held European pharmaceutical group with branded specialty and consumer health products including respiratory and ENT categories distributed across 30+ countries. Comparable as a privately held European specialty pharma with international OTC reach.
• Merz Pharma GmbH & Co. KGaA: Privately held German specialty pharmaceutical company with branded consumer health and specialty therapeutics distributed globally. Comparable as a family-owned, privately held European specialty pharma with branded OTC and medical device exposure.

Direct peers

• Klosterfrau Melisana GmbH: German traditional pharmaceutical company with branded OTC products in cough, cold, ENT, and travel sickness categories. Comparable given shared focus on ENT/respiratory OTC, German-speaking heritage, and traditional family-owned positioning.
• Engelhard Arzneimittel GmbH & Co. KG: German specialty pharmaceutical company focused on branded OTC and consumer health products in respiratory, cough/cold, and ENT categories. Direct peer in ENT and respiratory OTC specialty pharma in the DACH region.
• Bionorica SE: German specialty pharmaceutical company with strong focus on respiratory and ENT phytopharmaceutical products distributed internationally. Closest direct peer given shared ENT/respiratory therapeutic focus and European specialty pharma positioning.
• MoNo chem-pharm Produkte GmbH: Austrian pharmaceutical manufacturer and Sigmapharm's long-term strategic partner producing all of Sigmapharm's products. Operates in the same Vienna-based specialty pharma/medical device ecosystem with overlapping GMP-certified operations.

Regional players

• Gebro Pharma AG: Austrian pharmaceutical company headquartered in Fieberbrunn with branded specialty and generic products including pain, respiratory, and ENT indications. Highly comparable Austrian specialty pharma peer with overlapping therapeutic focus.
• Gerot Lannach GmbH: Austrian pharmaceutical company developing and manufacturing branded generics and specialty products, with distribution across European and international markets. Comparable in scale, geography, and specialty-pharma positioning.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/sigmapharm-arzneimittel-gmbh

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sigmapharm Arzneimittel